IRS Settlement Blocks Tax Audits Targeting Trump Family and Businesses Retirees May Explore ETF Blends to Close Monthly Income Gaps Kevin Warsh Faces Divided Fed as Inflation Pressures Complicate Rate Cut Debate Inflation Pressures Broaden Beyond Iran and Oil Shelter and Services Show Renewed Price Increases Charter Communications Revises Offer Secures Buyout Agreement for Liberty Broadband Paul Tudor Jones Says No Chance Kevin Warsh Would Cut Fed Rates BancFirst Corporation BANF Q1 2026 Earnings Solid EPS Beat Lifts Banks Start to Fiscal Year Heartflow Inc HTFL Q1 2026 Earnings EPS Misses Estimates Amid Key Operational Developments Accendra Health Inc ACH Q1 2026 Earnings EPS Beats Estimates with a 609 Surprise as Narrower Loss Fuels Investor Optimism PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Surprise of 254 Amid Stable Market Conditions GXO Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains BGMS Q3 2024 Earnings Narrowing Loss Beats Estimates by Wide Margin Thornburg Income Builder Opportunities Trust TBLD Gains 22 as IncomeFocused Funds Find Favor SunOpta STKL Holds Steady Near 650 as Shares Trade in a Tight Range Levi Strauss Co LEVI Stages Notable Advance Approaching Key Resistance BankUnited BKU Gains 214 Regional Bank Strength Tests Key Resistance Zone SuperCom SPCB Stalls Near Resistance as Slight Decline Tests Key Levels Morrisons Plans to Close 100 Stores Amid Rising Government Policy Costs Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss AIG Slips Modestly as Traders Eye Key Support Levels MINISO Q4 2025 Earnings Stellar EPS Beat Defies Market Sentiment Data Storage Corporation DTST Q1 2026 Earnings Earnings Surprise Driven by NarrowerThanExpected Loss FUFU Q4 2025 Earnings Massive EPS Miss Underscores Bitcoin Mining Headwinds NeoVolta NEOV Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence Stock Drops 2364 Birchtech Corp BCHT Q1 2026 Earnings EPS Miss Weighs on Shares Teck Resources Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines